Skip to main content
Log in

Platelet activating factor (PAF) and lyso-PAF in inflamed human skin

  • Proceedings of the Joint World Congress of the International Association of Inflammation Societies and the European Inflammation Society, Austria Center, Vienna, October 10–15, 1993
  • Skin Inflammation and Disease
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

The extent of PAF synthesis and its role in inflammatory skin disorders are not known. Skin exudates were collected from suction blisters or bbrasions on healthy and inflamed human skin and analysed by gc-ms. The mean PAF andlyso-PAF values for skin of healthy subjects were 1.86±0.92 (n=7) and 160±21 (n=8) nM, respectively, in suction blister exudates, and 0.38±0.08 (n=14) and 11.0±1.9 (n=13) pmol/abrasion, respectively. PAF levels were not altered in psoriasis, nickel contact dermatitis, delayed pressure urticaria, mastocytosis or immediate and late phase reactions to antigen. Significantly, lesslyso-PAF was found in uninvolved skin of psoriasis. Increasedlyso-PAF was found in nickel contact dermatitis compared with untreated skin of the same subjects or skin or normal healthy volunteers. We conclude that, if PAF is a significant mediator of inflammation in human skin, it may remain associated with the synthesising cell or act in its immediate proximity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. G. Camussi, C. Tetta and C. Baglioni,The role of platelet-activating factor in inflammation. Clin. Immunol. Immunopath.57, 331–338 (1990).

    Article  Google Scholar 

  2. C. B. Archer, C. P. Page, J. Morley and D. M. MacDonald,Accumulation of inflammatory cells in response to intracutaneous platelet activating factor. Br. J. Dermatol.112, 285–290 (1985).

    PubMed  Google Scholar 

  3. K. E. Grandel, R. S. Farr, A. A. Wanderer, T. C. Eisenstadt and S. I. Wasserman,Association of platelet-activating factor with primary acquired cold urticaria. New Engl. J. Med.313, 405–409 (1985).

    PubMed  Google Scholar 

  4. L. Michel, Y. Denizot, Y. Thomas, J. Benveniste and L. Doubertret,Release of PAF-acether and precursors during allergic cutaneous reactions. Lancet2 (8607), 404 (1987).

    Google Scholar 

  5. A. I. Mallet and F. Cunningham,Structural indentification of platelet activating factor in psoriatic scale. Biochem. Biophys. Res. Comm.126, 192–198 (1985).

    Article  PubMed  Google Scholar 

  6. R. M. Barr, F. Lawlor, M. R. Judge, P. Courtney, R. Barlow, A. Kobza Black, A. I. Mallet and M. W. Greaves,Platelet activating factor, lyso-platelet activating factor and arachidonic acid release in normal human skin and the influence of topical steroid treatment. Br. J. Clin. Pharmacol.35, 637–641 (1993).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barr, R.M., Judge, M., Mallet, A.I. et al. Platelet activating factor (PAF) and lyso-PAF in inflamed human skin. Agents and Actions 41 (Suppl 2), C260–C261 (1994). https://doi.org/10.1007/BF01987662

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01987662

Keywords

Navigation